International AIDS Vaccine Initiative Inc
International AIDS Vaccine (IAVI) is a public charity based in New York, NY, formed in 1996. It is a global nonprofit biomedical research organization that develops vaccines and antibodies for HIV, tuberculosis, and emerging infectious diseases, with research and clinical work intended to advance affordable, globally accessible public health solutions.
Key facts about International AIDS Vaccine Initiative Inc
In short: International AIDS Vaccine Initiative Inc gave $6.2M across 8 grants in 2025 (avg $771K), top state California. Source: 2025 IRS Form 990.
- EIN
- 13-3870223
- Latest 990 filing
- Form 990, 2025
- Annual giving (2025)
- $6,170,405
- Grants made (2025)
- 8
- Average grant
- $771,301
- Median grant
- $543,810
- Total assets
- $140,571,416
- Primary geography
- California (46% of itemized 2025 grant dollars)
Data from IRS Form 990, 2025; updated September 2026.
Financial Overview
From 2025 IRS Form 990 · View filing
Total Assets
$140.6M
+8.3% YoY
Annual Giving
$6.2M
-22.4% YoY
Grant Count
8
-66.7% YoY
Avg Grant Size
$771K
+132.8% YoY
How International AIDS Vaccine Initiative Inc gives
- Giving fell 47% from 2022 to 2025. Method
From the foundation's IRS Form 990 filings. Methodology.
Mission & Focus Areas
IAVI states that its mission is to translate scientific discoveries into affordable, globally accessible public health solutions. Its work includes HIV vaccine and antibody research; tuberculosis vaccine research; and vaccine development for emerging infectious diseases, including Lassa, Marburg, Sudan, and Bundibugyo virus diseases. Its website also describes work on neglected diseases and novel technologies.
The 2025 filing reports that IAVI supports external researchers with technical and scientific expertise and fosters collaborations among academia, industry, local communities, governments, and funders. Its listed 2025 grants were all for research and development. Among the grantees, Emory University describes its mission as creating, preserving, teaching, and applying knowledge in the service of humanity.
Grantmaking
In filing year 2025, IAVI reported eight grants totaling $6,170,405. Awards ranged from $39,028 to $2,460,785, with a median of $543,810. The largest grants went to The Scripps Research Institute - OSP ($2,460,785), FHI Clinical Inc. ($1,216,365), The Mitchell Group Inc. ($922,886), Seattle Children’s Hospital ($673,716), and Trustees of Boston University ($413,903). Each was designated for research and development. Emory University received $43,165 for research and development.
No application instructions or deadline are stated in the available information.
Ready to take the next step with International AIDS Vaccine Initiative Inc?
Geographic Focus
Where this funder awards grants
IAVI describes scientific and clinical research in Africa, India, Europe, and the United States, and says a significant portion of its supported research takes place in low-income countries. Its 2025 grants went to recipients in California, North Carolina, Washington, Massachusetts, Georgia, and New York, as well as the District of Columbia. California received 46% of grant dollars, North Carolina 20%, the District of Columbia 15%, Washington 11%, and Massachusetts 7%.
Grant Distribution by State
Share of 2025 grant dollars across all 8 itemized grants.
States
Cities
Giving Over Time
Total grant dollars and number of grants per year
From 2020 to 2025, annual grant giving ranged from $5.6M (2020) to $11.7M (2022). In 2025 it made 8 grants totaling $6.2M.
Grant Insights
How this funder distributes its grants
Top Recipients
Top 8 recipients in 2025
The largest 2025 recipient was The Scripps Research Institute - OSP ($2.5M). Together the top 8 received $6.2M.
Grant Size Distribution
96 grants across all recorded years
The most common grant size was in the $100–250K range: 25 grants of 96 (26%).
Giving History
Grant recipients and amounts by year
| Recipient | Purpose | Amount |
|---|---|---|
| The Scripps Research Institute - OSP La Jolla, CA | Research & Development | $2,460,785 |
| FHI Clinical Inc Durham, NC | Research & Development | $1,216,365 |
| The Mitchell Group Inc (TMG) Washington, DC | Research & Development | $922,886 |
| Seattle Children's Hospital Seattle, WA | Research & Development | $673,716 |
| Trustees of Boston University Boston, MA | Research & Development | $413,903 |
| La Jolla Institute for Allergy & Immunology La Jolla, CA | Research & Development | $400,557 |
| Emory University Atlanta, GA | Research & Development | $43,165 |
| SUNY Graduate School Albany, NY | Research & Development | $39,028 |
Financial History
Multi-year comparison from IRS filings
| Filing year | Assets | Revenue | Expenses | Grants |
|---|---|---|---|---|
| 2025 | $140,571,416 | $103,360,669 | $107,326,208 | $6,170,405 (8 grants) |
| 2024 | $129,852,638 | $131,181,475 | $143,043,595 | $7,951,405 (24 grants) |
| 2023 | $124,233,943 | $129,678,400 | $132,896,237 | $9,190,196 (23 grants) |
IAVI’s website reports 2022 revenue of $128.1 million, with 75.6% from governments, 24.1% from foundations and individuals, and 0.3% from other sources.
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Total Assets | $140,571,416 | $129,852,638 | $124,233,943 |
| Revenue | $103,360,669 | $131,181,475 | $129,678,400 |
| Expenses | $107,326,208 | $143,043,595 | $132,896,237 |
| Net Investment Income | $2,045,077 | $2,295,284 | $2,762,423 |
Data update history
When this profile's IRS filing data changed on Grantable
- Updated Form 990 for fiscal year 2020 (received by the IRS July 8, 2021)
- Updated Form 990 for fiscal year 2021 (received by the IRS August 2, 2022)
- Updated Form 990 for fiscal year 2022 (received by the IRS June 29, 2023)
- Updated Form 990 for fiscal year 2023 (received by the IRS July 22, 2024)
- Updated Form 990 for fiscal year 2024 (received by the IRS October 30, 2025)
- Added Form 990 for fiscal year 2025 (received by the IRS July 30, 2026)
- IRS filings on file for fiscal years 2020–2024
Leadership & Key People
Leadership team and compensation from IRS filings
The 2025 filing lists Mark B. Feinberg as president and CEO, and Eric Paul Goosby, MD, as board chair. Listed board members are Robert Goldberg, treasurer; Linda-Gail Becker; David Blumberg; Jim Connolly; Alexis M. Pinto; John W. Shiver; Susan Silbermann; and Anne Martin Simonds.
International AIDS Vaccine Initiative Inc is led by Mark B. Feinberg, President & CEO on every filing since 2020; 11 of 24 officers listed in 2025 are compensated.
Officers on the 2025 filing
Mark B. Feinberg
President & CEO
On filings since 2020
35 hrs/week
$614K (2020) → $706K (2025)
Eric Paul Goosby MD
Board Chair
On filings since 2020
2 hrs/week
No compensation reported
Ana Cespedes Montoya
Chief Operating Officer
On filings since 2020
35 hrs/week
$481K (2020) → $170K (2025)
Swati Gupta
Vice President, Head of Eid & Epidemiology
Vice President, Head of Eid & Epidemiology → Vice President, Head of Eid & Epidem., 2023
Vice President, Head of Eid & Epidem. → Vice President, Head of Eid & Epidemiology, 2024
On filings since 2020
35 hrs/week
$327K (2020) → $394K (2025)
Min Ding
General Counsel & Board Secretary
General Counsel & Secretary → General Counsel & Board Secretary, 2024
On filings since 2022
35 hrs/week
$325K (2022) → $357K (2025)
Mario Gagliano
Chief People Officer & Vice President of Hr
Cpo & Vice President of Hr → Chief People Officer & Vice President of Hr, 2024
On filings since 2023
35 hrs/week
$102K (2023) → $368K (2025)
Brandon Saft
Chief Financial Officer
Deputy Chief Financial Officer → Chief Financial Officer, 2025
On filings since 2024
35 hrs/week
$256K (2024) → $332K (2025)
Christopher Parksass Vp
Viral Vacc. & Head of Ddl
New on the 2025 filing
35 hrs/week
$377K (2025)
Jon Heinrichs
Vice President & Discovery Science
New on the 2025 filing
35 hrs/week
$374K (2025)
Kara Bickham
Chief Development Officer- Research Development
New on the 2025 filing
35 hrs/week
$415K (2025)
Louis D. Schwartzasst Sec
Chf.fin. & Administrator Officer
New on the 2025 filing
35 hrs/week
$3K (2025)
Richard W. Welch
Vice President, Bioprocess Development & Mfg.
New on the 2025 filing
35 hrs/week
$346K (2025)
Anne Martin Simonds
Board Member
On filings since 2020
1 hr/week
No compensation reported
David Blumberg
Board Member
On filings since 2020
1 hr/week
No compensation reported
Jim Connolly
Board Member
On filings since 2020
1 hr/week
No compensation reported
John W. Shiver
Board Member
On filings since 2020
1 hr/week
No compensation reported
Marijke Wijnroks
Board Member
On filings since 2020
1 hr/week
No compensation reported
Mark Dybul
Board Member
On filings since 2020
1 hr/week
No compensation reported
Rajeev Venkayya
Board Member
On filings since 2020
1 hr/week
No compensation reported
Robert Goldberg
Board Treasurer
On filings since 2020
2 hrs/week
No compensation reported
Alexis M. Pinto
Board Member
On filings since 2021
1 hr/week
No compensation reported
Susan Silbermann
Board Member
On filings since 2021
1 hr/week
No compensation reported
Wafaa El-Sadr
Board Member
On filings since 2021
1 hr/week
No compensation reported
Linda- Gail Becker
Board Member
New on the 2025 filing
1 hr/week
No compensation reported
Former officers (17)
- Former: Christopher Parks (2020–2024) — Ass. Vice President, Viral Vacc. & Head of Ddl
- Former: Dagna Laufer (2020–2024) — Vice President & Head of Clinical Development
- Former: Linda-Gail Becker (2020–2024) — Board Member
- Former: Louis D. Schwartz (2020–2024) — Assistant Secretary, Chief Finance & Administrator Officer
- Former: Sangeetha Sagar (2023–2024) — Vice President & Pdc
- Former: Marion Gruber (2024) — Vice President, Public Health & Reg. Science
- Former: Frances Sinha (2020–2023) — Former Officer
- Former: Christopher Parks - Assoc (2022–2023) — Assistant Vice President Viral Vac. & Head of Ddl
- Former: Eric Skjeveland (2022–2023) — Vice President & Business Development
- Former: John Nkengasong (2020–2022) — Board Member
- Former: Thomas Hassell (2020–2022) — Vice President & Pdc
- Former: Anne M. Vanlent (2020–2021) — Board Vice Chair
- Former: Francine Ntoumi (2020–2021) — Board Member
- Former: Labeeb Abboud (2020–2021) — Secretary Senior Vice President & General Counsel
- Former: William Ballou (2021) — Adv Senior Sci Advisor, Proj Lead & Hiv Bnabs
- Former: Margaret Keane (2020) — Vice President Global All. & Prod. Opt
- Former: Purnima Mane (2020) — Board Member
Data from IRS Form 990 filings, 2020–2025. "On filings since" is the earliest filing we hold that lists the person; hours are average hours per week as reported.
Compensation Overview
From 2025 IRS filing
The highest reported compensation on the 2025 filing was $706K, to Mark B Feinberg (President/CEO). 11 officers or directors reported compensation on that filing.
Contact
Mailing address: 125 Broad Street 9Th Fl, New York, NY 10004
Phone: (212) 847-1111
Website: https://iavi.org
Frequently asked questions about International AIDS Vaccine Initiative Inc
How much does International AIDS Vaccine Initiative Inc give each year?
International AIDS Vaccine Initiative Inc gave $6.2M across 8 grants in 2025, according to its 2025 IRS Form 990. In 2024 it gave $8.0M across 24 grants.
What is International AIDS Vaccine Initiative Inc's typical grant size?
International AIDS Vaccine Initiative Inc's median grant in 2025 was $543,810, and its average grant was $771,301, across 8 grants on its 2025 IRS Form 990.
Where does International AIDS Vaccine Initiative Inc give grants?
International AIDS Vaccine Initiative Inc's top state is California, with 46% of the grant dollars itemized on its 2025 IRS Form 990. The next largest states were North Carolina (20%) and District of Columbia (15%). The most frequent recipient cities were La Jolla, CA (2 grants).
Does International AIDS Vaccine Initiative Inc give general operating support?
Not in 2025: none of the 8 grants with a stated purpose on International AIDS Vaccine Initiative Inc's 2025 IRS Form 990 were described as general or operating support. Recurring purposes include "Research & Development" (8 grants).
Who are International AIDS Vaccine Initiative Inc's largest grantees?
International AIDS Vaccine Initiative Inc's largest 2025 grantees include The Scripps Research Institute - OSP ($2,460,785), FHI Clinical Inc ($1,216,365) and The Mitchell Group Inc (TMG) ($922,886), according to its 2025 IRS Form 990. Together they received 75% of its itemized 2025 grant dollars.
How large is International AIDS Vaccine Initiative Inc?
International AIDS Vaccine Initiative Inc reported $140.6M in total assets on its 2025 IRS Form 990. Its revenue that year was $103.4M.
What does International AIDS Vaccine Initiative Inc fund?
IAVI states that its mission is to translate scientific discoveries into affordable, globally accessible public health solutions. See mission & focus areas ↑
How do I apply for a grant from International AIDS Vaccine Initiative Inc?
International AIDS Vaccine Initiative Inc has no public application process in the sources Grantable reviewed. Check iavi.org for current guidelines, or contact the foundation directly before submitting a request.
What is International AIDS Vaccine Initiative Inc's EIN?
International AIDS Vaccine Initiative Inc's EIN (Employer Identification Number) is 13-3870223. IRS Form 990 filing data is available on this page for 2020–2025.
Data last updated September 2026. Sourced from IRS Form 990 filings. Research dossier generated September 2026.
Here's the math on researching International AIDS Vaccine Initiative Inc by hand.
Explore Open Grants
Browse active grant opportunities in International AIDS Vaccine Initiative Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Emory University
Atlanta, GA
Emory University primarily funds research and subcontract work for universities, hospitals, research organizations, and other organizations, across a range of academic and health-related fields. Its 2025 grants ranged from $5,500 to $19.1 million, with a median of about $97,000; 41% of grant dollars went to Georgia recipients. The profile does not state whether Emory accepts unsolicited requests.
Assets
$24.9B
Grants
362
Total Given
$183.7M
The Trustees of Columbia University in the City of New York
New York, NY
Columbia funds research, education and research, and capital projects, primarily through grants to universities and medical and research institutions across the United States, with the largest share going to New York recipients. Its 2025 grants had a median of about $109,000, though awards ranged from $5,350 to $15.1 million. The profile does not state whether it accepts unsolicited requests.
Assets
$26.0B
Grants
417
Total Given
$208.3M
The Simons Foundation Inc
New York, NY
The Simons Foundation funds research and public engagement in mathematics and the physical, life, autism, and neuroscience sciences. In 2024, it made 1,727 grants, with a median award of $72,000 and amounts ranging from $1,480 to $20 million, supporting organizations in the U.S. and internationally. It states that it funds only preselected charitable organizations and does not accept unsolicited requests.
Assets
$4.5B
Grants
1,727
Total Given
$272.0M
Trustees of Boston University
Boston, MA
The Trustees of Boston University funds university research and related academic, health, and campus programs, including work in neuroscience, clean energy, sustainability, health care delivery, and global health. Its 2025 grants ranged from $5,092 to $5.34 million, with a median of $125,223; funding was concentrated in Massachusetts and California. The profile does not state whether it accepts unsolicited requests.
Assets
$9.3B
Grants
268
Total Given
$109.8M
Georgetown University
Washington, DC
Georgetown University’s 2025 grants mainly supported research and related work through subawards to universities, hospitals, and nonprofits. It reported 191 grants totaling $27.9 million, with a median grant of $58,829; recipients were across the U.S., with the largest shares of funding going to DC and California. The stated application programs are limited to Georgetown faculty; whether it accepts unsolicited requests from outside organizations is not stated.
Assets
$6.9B
Grants
191
Total Given
$27.9M
Vanderbilt University Medical Center
Nashville, TN
Vanderbilt University Medical Center supports medical and scientific research, health and educational programs, and related institutional purposes, with grants to universities, medical centers, and research organizations. Its 2025 grants had a median of about $116,000, though awards ranged widely; recipients were based across the U.S., with the most funding going to Tennessee. The profile does not state whether it accepts unsolicited requests.
Assets
$7.8B
Grants
246
Total Given
$125.1M
Alzheimer's Disease & Related Disorders Association Inc
Chicago, IL
The Alzheimer’s Association funds Alzheimer’s and dementia research, including basic, clinical, social and behavioral studies, and supports care, prevention, early detection, awareness, and advocacy. In 2025, its 79 grants ranged from $10,000 to $13.3 million, with a median of $270,750; research opportunities are open to U.S. and international researchers.
Assets
$523.7M
Grants
79
Total Given
$73.3M
The Ford Foundation
New York, NY
The Ford Foundation funds organizations and initiatives working to reduce inequality and advance social justice, including work on civic engagement, civil rights, climate justice, disability rights, and technology and society. In 2024, its grants ranged from $45 to $15 million, with a median of $100,000, supporting work in the U.S. and internationally. It says most grants are identified by the foundation and it does not accept unsolicited proposals by mail, email, or phone; limited opportunities may be offered separately.
Assets
$17.5B
Grants
4,007
Total Given
$844.7M
The New York Community Trust
New York, NY
The New York Community Trust funds nonprofit programs in areas such as arts, education, health, the environment, workforce development, and youth development, including projects that improve services, build organizational capacity, or advance policy and systems change. Its competitive grants mainly serve New York City, Long Island, and Westchester, with some national and international environmental funding; the 2024 median grant was $20,000. The profile does not state whether it accepts unsolicited requests.
Assets
$3.5B
Grants
2,748
Total Given
$193.8M
More Funders in New York
The filing figures on this page are open data under CC BY 4.0. About GrantGraph Open
Figures come from International AIDS Vaccine Initiative Inc's IRS filings (methodology). AI-written summaries, news items and logos are not covered by the open licence. Spot an error? Email hello@grantable.co.
International AIDS Vaccine Initiative Inc down — hundreds of funders to go?